Drug Shortage Report for VISIPAQUE 270
| Report ID | 160506 |
| Drug Identification Number | 02145766 |
| Brand name | VISIPAQUE 270 |
| Common or Proper name | iodixanol injection USP |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IODIXANOL |
| Strength(s) | 550MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS |
| Packaging size | 200 mL |
| ATC code | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-07-15 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2022-05-13 |
| Company comments | Covid Related Shutdown in China. This is a fluid situation that we are working through daily. We will keep all customers informed on what orders to expect during this period so they can plan accordingly. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 canadainfo@ge.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2022-05-13 | French | Compare |
| v2 | 2022-05-13 | English | Compare |
| v1 | 2022-05-13 | English | Compare |
Showing 1 to 3 of 3